Clinical Trial of Lamotrigine to Reverse Cognitive Impairment in Chronic Corticosteroid-Treated Patients.
Phase of Trial: Phase IV
Latest Information Update: 02 Aug 2011
At a glance
- Drugs Lamotrigine (Primary)
- Indications Memory disorders
- Focus Therapeutic Use
- 02 Aug 2011 Actual initiation date (Aug 2002) added and additional lead trial centre, investigator identified as reported by ClinicalTrials.gov.
- 02 Aug 2011 Actual end date (Sep 2005) added as reported by ClinicalTrials.gov.
- 02 Aug 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT00223262).